Have you noticed any changes in your health since starting aspirin?

What changes do patients typically report after starting low-dose aspirin?

Many people notice no obvious effects, while others describe mild stomach discomfort or easier bruising within the first weeks. Larger studies show that daily low-dose aspirin reduces first heart attacks and ischemic strokes by roughly 10-15 percent in high-risk adults, but it also raises major bleeding risk by about 40 percent.

How soon do most people feel any difference?

Effects on blood clotting begin within hours of the first dose. Visible changes such as bruising or minor bleeding can appear in days, whereas cardiovascular protection builds over months to years of consistent use.

Why do some patients stop aspirin soon after starting?

Gastrointestinal irritation or bleeding is the most common reason. A 2023 review of real-world data found that 15-20 percent of new users discontinue within the first year, often citing stomach pain or physician advice after an ulcer or bleed.

What side effects are patients asking about online?

Search queries frequently mention easy bruising, nosebleeds, stomach upset, and tinnitus. Less common but serious concerns include gastrointestinal ulcers and hemorrhagic stroke. Forums show patients also ask whether aspirin interacts with ibuprofen, alcohol, or blood-pressure medicines.

Can you switch to a different blood thinner if aspirin causes problems?

Yes. Clinicians often move patients to clopidogrel, or to a combination of aspirin plus a P2Y12 inhibitor after stents. Choice depends on the reason aspirin was prescribed and individual bleeding risk.

When should you contact your doctor about new symptoms?

Report black stools, vomiting blood, severe headaches, or sudden weakness immediately. These can signal internal bleeding and require prompt evaluation.

How does aspirin compare with newer antiplatelet drugs?

Aspirin remains first-line for primary prevention in many guidelines because of low cost and decades of data. Newer agents such as ticagrelor or prasugrel show stronger clot prevention after heart attacks but carry higher bleeding rates and cost more.

Does aspirin still have a role once a patent or exclusivity period ends?

Aspirin lost patent protection decades ago, so generic versions are inexpensive and widely available. No new exclusivity periods apply, which keeps prices low and supports broad access.

What ongoing trials are examining aspirin’s future use?

Large studies continue to test aspirin in cancer prevention, preeclampsia, and long-COVID inflammation. Results may shift recommendations for lower-risk groups where bleeding risk currently outweighs benefit.

Sources
[1] https://drugpatentwatch.com
[2] Antithrombotic Trialists’ Collaboration. BMJ 2002;324:71-86.